Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAST: Pharmacological Management of Seizures Post TBI
NCT04573803Phase 3Not yet recruiting
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Mar 2021
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of phenytoin and levetiracetam in post-traumatic epilepsy (PTE) (5 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoints: Occurrence of late post-traumatic seizures at 24 months and Occurrence of post-traumatic seizures at 2 weeks. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
phenytoinlevetiracetam
03
Conditions
post-traumatic epilepsy (PTE)
Beyond the preview
Go deeper on NCT04573803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04573803.